![Aravind Arepally](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Aravind Arepally is the founder and had founded TriSalus Operating Life Sciences, Inc. in 2009, where he held the title of Chief Scientific Officer from 2013 to 2015.
He worked as an Associate Professor-Radiology at The Johns Hopkins University from 2000 to 2007.
Dr. Arepally received his undergraduate degree from Mercer University and his doctorate from Emory University School of Medicine.
Antiguos cargos conocidos de Aravind Arepally.
Empresas | Cargo | Fin |
---|---|---|
The Johns Hopkins University | Corporate Officer/Principal | 01/01/2007 |
TriSalus Operating Life Sciences, Inc.
![]() TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Fundador | - |
Formación de Aravind Arepally.
Mercer University | Undergraduate Degree |
Emory University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
TriSalus Operating Life Sciences, Inc.
![]() TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Health Technology |
- Bolsa de valores
- Insiders
- Aravind Arepally